Wells Fargo’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-40
| Closed | -$60 | – | 7383 |
|
|
2023
Q2 | $60 | Hold |
40
| – | – | ﹤0.01% | 6703 |
|
|
2023
Q1 | $70 | Buy |
40
+35
| +700% | +$61 | ﹤0.01% | 6701 |
|
|
2022
Q4 | $9 | Sell |
5
-6
| -55% | -$11 | ﹤0.01% | 7058 |
|
|
2022
Q3 | $0 | Buy |
11
+6
| +120% | – | ﹤0.01% | 7626 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 7690 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | – | – | 7741 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 7726 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 7579 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 7486 |
|
|
2021
Q1 | $1K | Sell |
13
-566
| -98% | -$43.5K | ﹤0.01% | 6456 |
|
|
2020
Q4 | $35K | Sell |
579
-225
| -28% | -$13.6K | ﹤0.01% | 5492 |
|
|
2020
Q3 | $108K | Buy |
804
+305
| +61% | +$41K | ﹤0.01% | 5042 |
|
|
2020
Q2 | $84K | Buy |
499
+57
| +13% | +$9.6K | ﹤0.01% | 5085 |
|
|
2020
Q1 | $64K | Buy |
442
+98
| +28% | +$14.2K | ﹤0.01% | 5052 |
|
|
2019
Q4 | $114K | Sell |
344
-15
| -4% | -$4.97K | ﹤0.01% | 5036 |
|
|
2019
Q3 | $179K | Buy |
359
+80
| +29% | +$39.9K | ﹤0.01% | 4828 |
|
|
2019
Q2 | $169K | Buy |
+279
| New | +$169K | ﹤0.01% | 4871 |
|
|
2018
Q4 | – | Sell |
-32
| Closed | -$22K | – | 6134 |
|
|
2018
Q3 | $22K | Buy |
32
+31
| +3,100% | +$21.3K | ﹤0.01% | 5470 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 5862 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 5846 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 5817 |
|
|
2017
Q3 | $2K | Buy |
+1
| New | +$2K | ﹤0.01% | 5763 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 5754 |
|